| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 16, 2004
Accepted on July 13, 2005
Pediatric Endocrinology Unit and General Pediatric Unit, Pediatric Department, Necker-Enfants Malades Hospital, Paris, Radiology Department, Foundation Rothschild and Pediatric Endocrinology, Armand Trousseau Hospital, Pierre et Marie Curie University, INSERM U 515, Paris, Genetics Department and Pediatric Radiology Unit, Necker-Enfants Malades Hospital, Paris, Pediatric Department, Besançon Hospital; France
* To whom correspondence should be addressed. E-mail: irene.netchine{at}trs.aphp.fr.
CONTEXT: CHARGE syndrome consists of a combination of congenital malformations including genital hypoplasia and retarded growth.
OBJECTIVE: To study gonadotropic axis function and growth parameters in CHARGE syndrome.
DESIGN: Retrospective study.
PATIENTS: 32 children with CHARGE syndrome.
RESULTS: Nineteen of 20 affected boys had micropenis and/or cryptorchidism, consistent with hypogonadotropic hypogonadism during fetal life. None of the boys was of pubertal age. Seven of nine boys tested before the age of five months during neonatal peak period had extremely low testosterone levels. LH response to GnRH stimulation was variable during the first year of life, and not correlated with existing clinical abnormalities. None of the girls over the age of 12 yr (n = 7) had begun puberty spontaneously and a lack of response to GnRH stimulation was documented in five of them. Olfactory evaluation (n = 10) and magnetic resonance imaging (n = 18) of the forebrain revealed defective sense of smell and abnormal olfactory bulbs in all cases.
Cardiorespiratory and nutritional problems were corrected but the mean height of the 25 children who had reached five years of age was -2 ± 0.2 SDS. Height was not correlated with birth length or body mass index. Growth hormone deficiency was diagnosed in only three children.
CONCLUSION: These findings suggest that CHARGE syndrome includes the main features of Kallmann syndrome which is defined by hypogonadotropic hypogonadism combined with a defective sense of smell and abnormal olfactory bulb development. This forebrain abnormality, if confirmed in a larger group of patients, could serve as a major new criterion for the diagnosis of CHARGE syndrome.
This article has been cited by other articles:
![]() |
Y. Asakura, Y. Toyota, K. Muroya, K. Kurosawa, K. Fujita, N. Aida, H. Kawame, K. Kosaki, and M. Adachi Endocrine and Radiological Studies in Patients with Molecularly Confirmed CHARGE Syndrome J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 920 - 924. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |